Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
Year: 2022
Type: article
Abstract: De-identified patient-level clinical and molecular data from NCT00046930 will be deposited into the National Institutes of Health’s NCTN/NCORP Data Archive ( https://nctn-data-archive.nci.nih.gov ) 6 months after publication. De-identified patient-level next generation sequencing data files will be deposited into the National Cancer Institute’s Cancer Data Service Portal ( https://datacommons.cancer.gov/repository/cancer-data-service ) 6 months after publication. Clinical and molecular data from validation cohort II are available upon request from [email protected]. This manuscript utilized data from Dataset NCT00049517-D2 from the NCTN/NCORP Data Archive of the National Cancer Institute’s (NCI’s) National Clinical Trials Network (NCTN). Data were originally collected from clinical trial NCT00049517 entitled “Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia”. All analyses and conclusions in this manuscript are the sole responsibility of the authors and do not necessarily reflect the opinions or views of the clinical trial investigators, the NCTN, the NCORP or the NCI. During the review process, requested data files were available upon request to editorial staff and reviewers through direct invitations from the corresponding author ([email protected]) to a confidential Box folder.
Source: Blood Cancer Journal
Authors: Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, Duane Hassane, Timour Baslan, Daniel T. Gildea, Samuel Haddox, Tak Lee, H. Moses Murdock, Caroline Sheridan, Alexis Thurmond, Ling Wang, Martin Carroll, Larry D. Cripe, Hugo Fernandez, Christopher E. Mason, Elisabeth Paietta, Gail J. Roboz, Zhuoxin Sun, Martin S. Tallman, Yanming Zhang, Mithat Gönen, Ross Levine, Ari M. Melnick, Maria Kleppe, Francine E. Garrett-Bakelman
Institutions: Memorial Sloan Kettering Cancer Center, Rockefeller University, University of Virginia, Weill Cornell Medicine, University of Pennsylvania, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Moffitt Cancer Center, Montefiore Medical Center, NewYork–Presbyterian Hospital, Dana-Farber Cancer Institute, University of Virginia Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,590
Funders: U.S. Department of Health and Human Services, Robert Wood Johnson Foundation, American Society of Hematology, Sanofi, Brigham and Women's Hospital, Leukemia Research Foundation, American College of Radiology Imaging Network, Memorial Sloan-Kettering Cancer Center, Northwestern University, Georgetown University, University of Virginia, New York Genome Center, Georgia Clinical and Translational Science Alliance, UVA Cancer Center, ECOG-ACRIN Cancer Research Group, National Institutes of Health, Weill Cornell Medical College, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, National Cancer Institute, National Center for Advancing Translational Sciences
Awards: G112449207, G1661467569, G1739225240, G1744647106, ECOG-ACRIN Network Group Operations Center, G2121288436, MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM, G2819266960, G3121473000, G332150848, G3475623468, Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center, G3746678611, G4015574465, G4191179286, G4335258714, G4382940005, G4508373442, G469290053, G4787186844, G5417201949, G5543716492, G581970335, G5883696104, G6076074778, G6705915398, G6720789042, G6916527643, ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER, G8220656038, Vanderbilt Network Lead Academic Participating Site for the NCTN, G9000022132, G9000113362, G9000126818, G9000146430, G9000182506, G9000199694, G9000202655, G9000253269, G9000327439, Cancer Center Support Grant, University of Virginia Cancer Center Support Grant, Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
OpenAlex ID: W4297020683